IP Library › Assignment 066155/0019
Patent Assignment
Reel/Frame 066155/0019

Security Interest

Recorded: 2024-01-17 Pages: 9
Assignor
EIDOS THERAPEUTICS, INC.
Executed: 2024-01-17
Assignee
ALTER DOMUS (US) LLC, AS COLLATERAL AGENT
225 WEST WASHINGTON STREET, 9TH FLOOR, CHICAGO, ILLINOIS, 60606
Covered Properties (8)
Processes For Preparing AG-10, Its Intermediates, and Salts Thereof
Application: 15/932,327 →
Publication: US 2018/0237396
Methods of Treating Ttr Amyloidosis Using AG10
Application: 16/361,587 →
Publication: US 2019/0290616
Formulations of AG10
Application: 16/542,737 →
Publication: US 2020/0054607
Processes for Preparing Ag-10, Its Intermediates, and Salts Thereof
Application: 16/676,931 →
Publication: US 2020/0247756
Processes for Preparing Ag-10, Its Intermediates, and Salts Thereof
Application: 17/350,066 →
Publication: US 2022/0041558
Formulations of AG10
Application: 17/577,479 →
Publication: US 2022/0313661
Potent Transthyretin (Ttr) Stabilization in Ttr Amyloidosis Patients Receiving Acoramidis
Application: 63/487,801 →
Potent Transthyretin (Ttr) Stabilization in Ttr Amyloidosis Patients Receiving Acoramidis
Application: 63/516,757 →
Related Assignments (12)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 22, 2019
From: CHAND, POORAN; GUPTA, YOGESH KUMAR; KUMAWAT, RAKESH KUMAR; ALHAMADSHEH, MAMOUN
To: EIDOS THERAPEUTICS, INC.
Reel/Frame 048671/0933 →
Assignment of Assignor's Interest Jul 23, 2019
From: SINHA, UMA; RAO, SATISH
To: EIDOS THERAPEUTICS, INC.
Reel/Frame 049838/0284 →
Assignment of Assignor's Interest Nov 12, 2019
From: JERNELIUS, JESPER; MENNING, MARK MICHAEL
To: EIDOS THERAPEUTICS, INC.
Reel/Frame 050986/0980 →
Assignment of Assignor's Interest Apr 22, 2020
From: CHAND, POORAN; GUPTA, YOGESH KUMAR; KUMAWAT, RAKESH KUMAR; ALHAMADSHEH, MAMOUN
To: EIDOS THERAPEUTICS, INC.
Reel/Frame 052467/0650 →
Assignment of Assignor's Interest Oct 29, 2021
From: CHAND, POORAN; GUPTA, YOGESH KUMAR; KUMAWAT, RAKESH KUMAR; ALHAMADSHEH, MAMOUN
To: EIDOS THERAPEUTICS, INC.
Reel/Frame 057962/0195 →
Security Interest Nov 17, 2021
From: BRIDGEBIO PHARMA, INC.; ORIGIN BIOSCIENCES, INC.; EIDOS THERAPEUTICS, INC.; QED THERAPEUTICS, INC.
To: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 058144/0302 →
Assignment of Assignor's Interest Jun 29, 2022
From: JERNELIUS, JESPER; MENNING, MARK MICHAEL
To: EIDOS THERAPEUTICS, INC.
Reel/Frame 060360/0433 →
Security Interest Jan 17, 2024
From: CALCILYTIX THERAPEUTICS INC.; ADRENAS THERAPEUTICS INC.; PHOENIX TISSUE REPAIR, INC.; NAVIRE PHARMA, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066342/0154 →
Release of Security Interest Jan 18, 2024
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS SUCCESSOR TO U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: BRIDGEBIO PHARMA, INC.; ORIGIN BIOSCIENCES, INC.; EIDOS THERAPEUTICS, INC.; QED THERAPEUTICS, INC.
Reel/Frame 066167/0462 →
Security Interest Jan 19, 2024
From: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; THERAS, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066355/0126 →
Assignment of Assignor's Interest Mar 18, 2024
From: SINHA, UMA; JI, ALAN X.; WONG, PAUL
To: EIDOS THERAPEUTICS, INC.
Reel/Frame 066806/0280 →
Release of Security Interest in Patent Collateral Mar 5, 2025
From: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; ML BIO SOLUTIONS INC.
Reel/Frame 070551/0095 →